ОбзорГрафикНовостиTraderScreen

UC DIS.CERT. 12/24 BRM/  DE000HC8REC3  /

gettex Zertifikate
15.11.2024  21:46:52 Изменение-0.040 Бид21:50:47 Предложение21:50:47 Базовый актив Цена исполнения Дата истечения Тип опциона
49.060EUR -0.08% 49.060
Величина цены спроса: 6,000		 49.090
Величина цены предложения: 6,000		 BRISTOL-MYERS SQUIBB... - - 31.12.2024 Call
TeleTrader 11.11 US closes mostly higher ahead of inflation data
TeleTrader 11.11 Dow gains 330 points at open after record week
GlobeNewswire 03.09 Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer
GlobeNewswire 02.09 CSE Announces its 2024 Sustainability & ESG Leadership Summit at NYC's One World Trade Center
GlobeNewswire 30.08 Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment Conference
GlobeNewswire 29.08 Immunocore announces transition of Chief Financial Officer
GlobeNewswire 28.08 Hematologists Highlight Ongoing Challenges in Sickle Cell Disease and Thalassemia Amidst Promising A...
GlobeNewswire 22.08 Abata Therapeutics Receives FDA Fast Track Designation for ABA-101 for the Treatment of Progressive ...
GlobeNewswire 15.08 Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement o...
GlobeNewswire 12.08 Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in C...
Newsfile Corp 12.08 The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
GlobeNewswire 12.08 Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer
GlobeNewswire 08.08 CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 07.08 Efficacy and Safety Data of Sotagliflozin in Patients with Type 1 Diabetes and Chronic Kidney Diseas...
GlobeNewswire 06.08 ALX Oncology Appoints Alan Sandler, M.D., to Board of Directors
GlobeNewswire 05.08 iTeos Therapeutics Announces Appointment of David Feltquate as Chief Medical Officer
GlobeNewswire 01.08 Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies i...
GlobeNewswire 01.08 CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024
GlobeNewswire 31.07 Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Boar...
GlobeNewswire 30.07 Anaveon appoints Dieter Weinand as Chair of its Board of Directors
GlobeNewswire 25.07 Purple Biotech Receives Extension to Regain Compliance with the Nasdaq’s Minimum Bid Price Rule
GlobeNewswire 24.07 Prota Therapeutics Strengthens Board with Appointment of Global Biotech Expert Patrick Machado
GlobeNewswire 20.07 NCLA Asks Third Circuit to Rule Against HHS’s Coercive Medicare Drug Price ‘Negotiation’ Program
GlobeNewswire 17.07 Nouscom Appoints Tiffany Muller as Chief Financial Officer and Loredana Siani as Senior Vice Preside...
GlobeNewswire 09.07 VYNE Therapeutics Announces Appointment of Subhashis Banerjee, M.D. as Senior Vice President of Clin...